Devonian Reports Distribution Agreement Termination
Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused ...
Lilly's Growth in Diabetes and Obesity, and Strong Oncology and Immunology Drugs Create a Wide Moat
Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...
dermatologyadvisor2d
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Medscape3d
Stick-on AI Hand Sensor Reduces Nighttime Scratching in Mild Atopic Dermatitis
A small cohort study found that a wearable hand sensor that uses artificial intelligence reduced subconscious nighttime ...
Devonian Health Group Inc. Reports Superior Anti-Inflammatory Potency of Thykamine™ in Comparative In Vitro Study
Detailed price information for Devonian Health Group Inc (GSD-X) from The Globe and Mail including charting and trades.
Positive Outlook for Arcutis Biotherapeutics Despite Temporary Prescription Declines
Mizuho Securities analyst Uy Ear has maintained their bullish stance on ARQT stock, giving a Buy rating on January 29.Maximize Your Portfolio ...